Prospeo
Hero Section BackgroundHero Section Background
FLYPHARMA

FLYPHARMA Revenue

Biotechnology Research1-10 Employees

$

FLYPHARMA revenue & valuation

Annual revenue$85,555
Revenue per employee$86,000
Estimated valuation?$273,776
Total fundingNo funding

Key Contact at FLYPHARMA

Flag of HK

Constant Tedder

Chief Executive Officer

Company overview

HeadquartersXX
Website
NAICS541714
Keywords
Therapeutics, Biologics, Biomanufacturing, Bioconversion
Founded2025
Employees1-10

About FLYPHARMA

FlyPharma is a biomanufacturing company pioneering the next generation of biologics through advanced insect bioconversion technologies. Our mission is to make life-saving and life-enhancing biologics radically more affordable and accessible — not just for human health, but also for animal health, where demand for scalable solutions is rapidly accelerating. Traditional biologics manufacturing is expensive, centralised, and limited to a handful of facilities worldwide. FlyPharma is changing this by engineering genetically enhanced Black Soldier Fly (BSF) strains to act as natural bioreactors, producing high-value proteins such as monoclonal antibodies (mAbs) at a fraction of conventional costs. By integrating modular production systems with automation, robotics, and AI-driven controls, we are building a platform that can be rapidly deployed, scaled, and adapted to diverse global markets. Our initial focus is on the animal health sector, where rising protein demand, antibiotic resistance, and sustainability pressures create an urgent need for breakthrough solutions. FlyPharma’s mAb-enriched products offer new pathways to improve livestock health and performance while reducing reliance on antibiotics — a transformative step for both productivity and global food security. From poultry and swine to aquaculture, our technology opens doors to multi-billion-dollar markets. At the same time, our vision extends into human health. By proving our platform in animal applications first, we are building the foundation for low-cost biologics that could one day reshape access to treatments for millions of people worldwide. With active pilot projects, global industry partnerships, and a strong innovation pipeline, FlyPharma is positioned at the intersection of biotechnology, sustainability, and industrial scale-up. We are not just lowering costs — we are redefining what’s possible in biomanufacturing. Upcycling waste. Transforming food. Democratizing biologics.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

FLYPHARMA has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

FLYPHARMA has never raised funding before.

Frequently asked questions

FLYPHARMA is located in XX.
FLYPHARMA generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.
FLYPHARMA has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
FLYPHARMA was founded in 2025, making it 1 years old. The company has established itself as a significant player in its industry over this time.
FLYPHARMA has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles